SIMCor (In-Silico testing and validation of Cardiovascular IMplantable devices)
Published July 19, 2023 | Version v1
Presentation Open

From engineering metrics to clinical endpoints

Creators

  • 1. ROR icon Biotronik (Germany)

Description

SIMCor (In-Silico testing and validation of Cardiovascular IMplantable devices) has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101017578.

Files

ESB2023_pre-course-series_IV_2-From-engineering-metrics-to-clinical-outcomes.pdf

Files (683.3 kB)

Additional details

Funding

European Commission
SIMCOR – In Silico testing and validation of Cardiovascular Implantable devices 101017578